Comments

maqbool ahmed (Guest)
11th Dec 2017 at 03:36 pm
good analysis with pharma sector is slowly catching the trend it is worth to invest
Yuvanesh
8th Dec 2017 at 02:12 pm
Thank u for the analysis. Accurate as always
Srini (Guest)
7th Dec 2017 at 05:29 pm
I appreciate your good analysis & comparison, very much helpful.. Thank you very much.
Shyamlal Chettiar
7th Dec 2017 at 01:31 pm
Good. So it is an avoid
Rina Kumari
6th Dec 2017 at 09:55 pm
Very good analysis Lt point of vew very good
ASHOK JAIN
6th Dec 2017 at 01:30 pm
Very good information.*****
Rajeev Gupta
6th Dec 2017 at 08:47 am
Thanks! for mentioning Listing date as well.
Vivek Shah (Guest)
5th Dec 2017 at 10:10 pm
Good one! Thank you!
Anil Kohli
5th Dec 2017 at 08:59 pm
If you read inbetween the lines, the issue is an avoid
RamaRajuKV
5th Dec 2017 at 06:04 pm
I take all your advises very critically
Arvind A Desai
5th Dec 2017 at 03:29 pm
The one risk that I see is regulatory risk [ central or state ] to please the population in general . Already happening in some states .
DVN SATYANARAYANA
5th Dec 2017 at 12:34 pm
Good analysis, sir I am listening u on CNBC TV
Premjit Singh Dhillon
5th Dec 2017 at 12:03 pm
Very useful & detailed analysis.
Prabhakar (Guest)
5th Dec 2017 at 11:29 am
It is very useful to have such data and your analysis is quite helpful to invest.I am a fan of sri. Sp tulsian
Ashwin (Guest)
5th Dec 2017 at 11:27 am
Good Analysis with so many information
Post a Comment Cancel